Copyright
©The Author(s) 2025.
Artif Intell Gastroenterol. Jun 8, 2025; 6(1): 106149
Published online Jun 8, 2025. doi: 10.35712/aig.v6.i1.106149
Published online Jun 8, 2025. doi: 10.35712/aig.v6.i1.106149
Table 5 Overview of commercially available artificial intelligence systems and the key distinctions among them
Characteristics | GI genius | CAD EYE | EndoScreener | ENDO-AID | SOKUT | Endoangel |
Developer | Medtronic | Fujifilm | Beijing-based company weiming vision technology | Olympus | Iterative | Wuhan endoangel medical technology co |
AI function | CADe | CADe + CADx | CADe | CADe + CADx | CADe | CADe + CADx |
System description | Real-time polyp detection with visual/audio alerts. Integrated with HD colonoscopes | Optimized for Fujifilm scopes. Useful for optical biopsy | Compatible with multiple endoscope brands. High sensitivity for small polyps. Validated in Chinese populations | Focuses on adenoma detection. Trained for sessile adenoma. Validated in United States multicenter trials | Focus in adenoma detection and diagnosis. Can assess bowel preparation quality. Additional benefit in diagnosis gastric neoplasm | |
Regulatory approval | United States Food and Drug Administration Europe, Select markets in Asia, Australia, and the Middle East | Pharmaceuticals and Medical Devices Agency (Japan). United States Food and Drug Administration | National Medical Products Administration (China) | Europe, Middle East, Africa. United States Food and Drug Administration | United States Food and Drug Administration | National Medical Products Administration (China) |
Workflow integration | Flexible | Fujifilm-only | Flexible | Olympus-only | Flexible | Flexible |
Clinical adaption | United State. Europe | Japan | China | Japan. Europe | United State | China |
ADR improvement | Consistent ADR. Lower non-neoplastic resection. Prolonged withdrawal time. No improvement with SSL | Prioritize large/advanced adenoma. Less sensitive over subtle and small adenoma. No improvement with SSL | Improvement in ADR. Increase non-neoplastic resection | Consistent ADR. Significant SSL benefits | Improvement in ADR. Increase non-neoplastic resection | Real-time detection and withdrawal time monitoring. Alerts for suboptimal technique. Improves withdrawal technique. Reduces miss rates |
- Citation: Aleissa MA, Luca M, Singh JP, Chitragari G, Drelichman ER, Mittal VK, Bhullar JS. Current status of artificial intelligence colonoscopy on improving adenoma detection rate based on systematic review of multiple metanalysis. Artif Intell Gastroenterol 2025; 6(1): 106149
- URL: https://www.wjgnet.com/2644-3236/full/v6/i1/106149.htm
- DOI: https://dx.doi.org/10.35712/aig.v6.i1.106149